Skip to content

Investigator

Vadim Jucaud

TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION · funded by NIAID

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$1.1M

Summed across those awards.

First award
Aug 14, 2024

Latest Feb 2, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Vascularized porcine liver on-a-chip modeling human xenoimmunity

    $492k

    Feb 2, 2026NIAIDTERASAKI INSTITUTE FOR BIOMEDICAL INNOVATIONNIH RePORTER · 11305050 (opens the source filing in a new tab)

  2. R01

    Vascularized liver-heart on-a-chip modeling antibody-mediated rejection and tolerance of allografts

    $611k

    Aug 14, 2024NIAIDTERASAKI INSTITUTE FOR BIOMEDICAL INNOVATIONNIH RePORTER · 11169690 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources